Constant monitoring needed for new MS treatments

Advances in the treatment of multiple sclerosis have been good news for patients, but side- effects and risks mean that active management strategy and constant monitoring are essential, advise the authors of a Clinical Focus published online by the Medical Journal of Australia.

The authors, including Professor Simon Broadley from the Griffith University School of Medicine on the Gold Coast, warned that "most of the newer, more effective therapies are associated with risks and practical problems that necessitate an active management strategy and continuous vigilance".

Favicon of da :

Prosegui la lettura...
Traduci l'articolo...

Sclerosi Multipla News

Potrebbe interessarti anche

Argomenti correlati